Evidence map›Paper›PMID 38836117›Full record

ArticleFrontiers in molecular neuroscience2024

Identification of crucial inflammaging related risk factors in multiple sclerosis.

Mengchu Xu, Huize Wang, Siwei Ren, Bing Wang, Wenyan Yang, Ling Lv, Xianzheng Sha, Wenya Li, Yin Wang

Abstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Microglia in Brain Aging and Age-Related Diseases: Friends or Foes?International journal of molecular sciences · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mengchu Xu *Department of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.
Huize Wang *Department of Nursing, First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China.
Siwei RenDepartment of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.
Bing WangDepartment of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.
Wenyan YangDepartment of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.
Ling LvDepartment of Thorax, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Xianzheng ShaDepartment of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.
Wenya LiDepartment of Thorax, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Yin WangDepartment of Biomedical Engineering, School of Intelligent Sciences, China Medical University, Shenyang, Liaoning, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Multiple sclerosis (MS) is an immune-mediated disease characterized by inflammatory demyelinating lesions in the central nervous system. Studies have shown that the inflammation is vital to both the onset and progression of MS, where aging plays a key role in it. However, the potential mechanisms on how aging-related inflammation (inflammaging) promotes MS have not been fully understood. Therefore, there is an urgent need to integrate the underlying mechanisms between inflammaging and MS, where meaningful prediction models are needed. Methods: First, both aging and disease models were developed using machine learning methods, respectively. Then, an integrated inflammaging model was used to identify relative risk factors, by identifying essential "aging-inflammation-disease" triples. Finally, a series of bioinformatics analyses (including network analysis, enrichment analysis, sensitivity analysis, and pan-cancer analysis) were further used to explore the potential mechanisms between inflammaging and MS. Results: A series of risk factors were identified, such as the protein homeostasis, cellular homeostasis, neurodevelopment and energy metabolism. The inflammaging indices were further validated in different cancer types. Therefore, various risk factors were integrated, and even both the theories of inflammaging and immunosenescence were further confirmed. Conclusion: In conclusion, our study systematically investigated the potential relationships between inflammaging and MS through a series of computational approaches, and could present a novel thought for other aging-related diseases.

Indexed as

inflammagingmachine learningmultiple sclerosisnetwork analysispan-cancer analysis

Identifiers

PMID38836117
PMCPMC11148336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.